POSTMENOPAUSE
Clinical trials for POSTMENOPAUSE explained in plain language.
Never miss a new study
Get alerted when new POSTMENOPAUSE trials appear
Sign up with your email to follow new studies for POSTMENOPAUSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Exercise plus hormone therapy may cut heart risk in menopause
Disease control Recruiting nowThis study looks at whether combining hormone replacement therapy with a supervised exercise program can improve body composition, heart health, and insulin sensitivity in postmenopausal women. Researchers will follow 390 women over 24 weeks, measuring changes in cardiovascular r…
Matched conditions: POSTMENOPAUSE
Phase: NA • Sponsor: University Hospital, Ghent • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can a daily pill slow aging? new trial tests GLYLO supplement in postmenopausal women
Disease control Recruiting nowThis pilot study tests whether a dietary supplement called GLYLO can lower harmful compounds called AGEs in overweight or obese postmenopausal women aged 45-65. Participants take either GLYLO or a placebo for 24 weeks, and researchers measure changes in AGEs, insulin resistance, …
Matched conditions: POSTMENOPAUSE
Phase: NA • Sponsor: Buck Institute for Research on Aging • Aim: Disease control
Last updated Jun 26, 2026 15:12 UTC
-
Exercise before breast cancer surgery may fight fatigue and muscle loss
Symptom relief Recruiting nowThis study looks at whether starting resistance exercise training before breast cancer surgery can help reduce common side effects like fatigue, muscle loss, and reduced strength. The study involves 68 postmenopausal women with breast cancer who are scheduled for chemotherapy bef…
Matched conditions: POSTMENOPAUSE
Phase: NA • Sponsor: Universidad de La Frontera • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Smoking may change how this drug works in postmenopausal women
Knowledge-focused Recruiting nowThis study tests whether smoking changes how the body processes a single dose of GS1-144 tablets. It involves 24 healthy Chinese women aged 40-65 who are postmenopausal. Researchers will measure drug levels in the blood to see if smoking affects the drug's breakdown. The goal is …
Matched conditions: POSTMENOPAUSE
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC